NCT06271135

Brief Summary

The study population consisted of 160 patients (123 women and 37 men) with rosacea, who agreed to participate in this study. Patients were qualified for the study among people visiting the cosmetic studio in Choroszcz in the period from June 2017 to November 2018, based on the diagnosis of a dermatologist and cosmetologist. The cosmetic intervention was performed using CAPILLARY REPAIR SERUM (30ml). Study participants completed self-reported questionnaire and standardized questionnaires.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
160

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started May 2017

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 8, 2017

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2018

Completed
5.2 years until next milestone

First Submitted

Initial submission to the registry

February 6, 2024

Completed
15 days until next milestone

First Posted

Study publicly available on registry

February 21, 2024

Completed
Last Updated

February 21, 2024

Status Verified

February 1, 2024

Enrollment Period

1.6 years

First QC Date

February 6, 2024

Last Update Submit

February 14, 2024

Conditions

Keywords

quality of lifecosmetics procedureslifestyledietary antioxidants

Outcome Measures

Primary Outcomes (1)

  • Elements influenced on quality of life of participants with rosacea

    The aim of the study was to assess whether antioxidant cosmetic procedures and selected lifestyle elements, especially dietary antioxidants have a significant impact on the quality of life of patients with rosacea.

    17 months

Secondary Outcomes (6)

  • Self-reported questionnaire

    17 months

  • Dietary Questionnaire

    17 months

  • The Physical Activity Questionnaire

    17 months

  • DLQI (Dermatology Life Quality Index)

    17 months

  • SWLS (Satisfaction With Life Scale)

    17 months

  • +1 more secondary outcomes

Study Arms (1)

Participants with rosacea

EXPERIMENTAL
Behavioral: CAPILLARY REPAIR SERUM 30ml

Interventions

Cosmetic procedures were performed on a group of patients after a cosmetic interview containing questions about contraindications to the procedure. The treatment was performed 3-times at 2-week intervals and consisted of cavitation peeling and sonophore-sis with an antioxidant preparation dedicated to vascular skin. The F-808 Skin Scrubber device was used for the treatment. After a month, the procedure was repeated. The stages of a cosmetologist's procedure during a cosmetic intervention were as follows: 1. make-up removal; 2. skin diagnostics, exclusion of contraindications, discussion of the procedure; 3. cavitation peeling - gentle skin cleansing using ultrasound; 4. applying an antioxidant cosmetic mixture (composition: rutin, horse chestnut and arnica extract, acerola, vitamin C, moisturizing complex of algae); 5. performing sonophoresis treatment; 6. applying the cream at the end; 7. discussion of indications for further care.

Participants with rosacea

Eligibility Criteria

Age30 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • diagnosis of rosacea according to the criteria of the National Rosacea Society Expert Committee (NRSEC) from 2019,
  • tolerance to the ingredients of the preparation used in the cosmetic intervention,
  • lack of pregnancy and lactation,
  • completion of a survey,
  • signed informed consent

You may not qualify if:

  • age \< 30 years,
  • patients with other facial skin diseases (e.g. acne, psoriasis, eczema),
  • intolerance to the ingredients of the preparation used in the cosmetic treatment,
  • patients with neuropsychiatric diseases, pregnancy, lactation,
  • patients who did not sign informed consent to participate in the study
  • did not complete the survey questionnaire.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Medical University of Bialystok

Bialystok, 15-089, Poland

Location

MeSH Terms

Conditions

Rosacea

Condition Hierarchy (Ancestors)

Skin DiseasesSkin and Connective Tissue Diseases

Study Officials

  • Małgorzata E Zujko, Dr.

    Medical Univeristy of Bialystok

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 6, 2024

First Posted

February 21, 2024

Study Start

May 8, 2017

Primary Completion

November 30, 2018

Study Completion

November 30, 2018

Last Updated

February 21, 2024

Record last verified: 2024-02

Locations